Valeant Pharmaceuticals International Inc

(

VRX

) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 1.8%. By the end of trading, Valeant Pharmaceuticals International Inc fell $1.47 (-3.6%) to $39.56 on light volume. Throughout the day, two million shares of Valeant Pharmaceuticals International Inc exchanged hands as compared to its average daily volume of 3.4 million shares. The stock ranged in price between $39.55-$40.61 after having opened the day at $40.23 as compared to the previous trading day's close of $41.03. Other company's within the Health Care sector that declined today were:

NPS Pharmaceuticals Inc

(

NPSP

), down 33.4%,

Integra LifeSciences Holdings Inc

(

IART

), down 16.4%,

BioMimetic Therapeutics Inc

(

BMTI

), down 11.7%, and

BioSpecifics Technologies Corporation

(

BSTC

), down 10.9%.

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. Its product portfolio comprises approximately 490 products. Valeant Pharmaceuticals International Inc has a market cap of $11.6 billion and is part of the

drugs

industry. Shares are up 44.2% year to date as of the close of trading on Friday.

TheStreet Ratings rates Valeant Pharmaceuticals International as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and disappointing return on equity.

On the positive front,

Momenta Pharmaceuticals Inc

(

MNTA

), up 20.9%,

Cormedix Inc

(

CRMD

), up 16.7%,

Zalicus Inc

(

ZLCS

), up 15.8%, and

Complete Genomics Inc

(

GNOM

), up 14%, were all gainers within the health care sector with

Mindray Medical International

(

MR

) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null